2004

New Carotid Stent System Offers Minimally Invasive Alternative to Open Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...

Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced a collaboration...

Company to Reiterate Third Quarter and Full-Year Guidance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call today, Thursday, , at...

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its regularly scheduled mid-quarter conference call to provide an update on the...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...

Advanced Leads and Lead Delivery System Further Strengthen Company''s Heart Failure Portfolio Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...

U.S. Food and Drug Administration Advisory Committee Approval Based on Data from Company''s Landmark COMPANION Heart Failure Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation...

New Rapid-Exchange Dilatation Catheter Provides Foundation for Successful Interventional Procedures Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the...

Sales led by strong growth in worldwide implantable defibrillators Worldwide implantable defibrillator revenue of $456 million, up 21 percent Worldwide pacemaker revenue of $183 million, up 7 percent

Innovative System Combines Treatments for Heart Failure, Atrial Arrhythmias and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...